NCT03594786
Unknown
Not Applicable
To Assess Hemodynamic Disturbances to the Ostia of the Renal Arteries Generated by the Implantation of EVAR With a Suprarenal Fixation
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Aortic Aneurysm, Abdominal
- Sponsor
- Centre Hospitalier Universitaire de Besancon
- Enrollment
- 70
- Locations
- 2
- Primary Endpoint
- systolic maximum speed at the ostia of the renal arteries
- Last Updated
- 6 years ago
Overview
Brief Summary
The investigators conducted a bicentric prospective study to quantify the hemodynamic disturbances to the ostia of the renal arteries generated by the implantation EVAR with suprarenal fixation immediately postoperatively.
Investigators
Eligibility Criteria
Inclusion Criteria
- •elective EVAR with supra renal fixation
- •women who have been postmenopausal for at least 24 months or are surgically sterilized, or for women of childbearing potential, use of an effective method of contraception
- •consent to participate
- •Affiliation to a French social security
Exclusion Criteria
- •stenosis of at least one renal artery
- •rupture of abdominal aortic aneurysm
- •renal stenting during the procedure
- •fenestrated EVAR
- •legal incapacity or limited legal capacity
- •subject being in the exclusion period of another study
- •pregnant woman
Outcomes
Primary Outcomes
systolic maximum speed at the ostia of the renal arteries
Time Frame: one month
Quantify the hemodynamic disturbances to the ostia of the renal arteries generated by the implantation of a suprarenal fixation aortic stent immediately postoperatively.
Secondary Outcomes
- proportion of decrease of the resistance index(one year)
- proportion of disappearance of the "notch" (pre-systolic notch)(one year)
- systolic maximum speed at the ostia of the renal arteries(one year)
- proportion of patients with renal artery stenosis(one year)
- proportion of increase in systolic rise time(one year)
- proportion of post-stenotic turbulence(one year)
- glomerular filtration rate(one year)
Study Sites (2)
Loading locations...
Similar Trials
Active, not recruiting
Not Applicable
A Phase II Study to assess the hemodynamic effects of ISTAROXIME, a novel lusinotropic agent, in patients hospitalized with worsening heart failure and a reduced left ventricular systolic function. - The Horizon-HF TrialChronic heart failure and left ventricular systolic dysfunctionMedDRA version: 8.1Level: LLTClassification code 10008908Term: Chronic heart failureEUCTR2005-004972-20-GRSigma-Tau i.f.r. S.p.A.120
Recruiting
Not Applicable
Clinical study to evaluate hemodynamic change in exercise test with or without protective maskKCT0005235Chungbuk National University Hospital90
Unknown
Not Applicable
Hemodynamic Implications of Transcatheter Tricuspid Valve Repair in HFpEF PatientsCongestive Heart FailureTricuspid RegurgitationNCT04782908Heart Center Leipzig - University Hospital20
Completed
Not Applicable
An Examination of the Effect on Various Factors of Bed Baths Applied by Two Different Methods in Intensive Care PatientsPatient CareNCT05310825Uludag University22
Recruiting
Not Applicable
Local Cerebral Oxygenation in Chronic Pain Patients Utilizing Spinal Cord StimulationChronic PainNCT06559735CereVu Medical, Inc.25